Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial

Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to reflect an increase in study locations from 423 to 430, with several new recruiting sites added in various countries, including the United States, Canada, and Georgia. Additionally, some outdated contact information and locations have been removed.
    Difference
    2%
    Check dated 2025-06-14T13:48:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-07T05:41:18.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now indicates that the study has increased from 422 to 423 locations and has updated contact information for the Study Coordinator in Englewood, Colorado. Additionally, the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input.
    Difference
    0.6%
    Check dated 2025-05-31T00:24:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The webpage has updated its study locations, increasing the total from 413 to 422, and has added several new recruiting sites across various countries, including Spain, Slovakia, and the United States. Additionally, some registry identifiers have been removed.
    Difference
    6%
    Check dated 2025-05-23T18:05:07.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new clinical trial protocol for evaluating the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis, including new study details, locations, and contact information. The trial now includes a broader range of recruiting sites across various countries.
    Difference
    45%
    Check dated 2025-04-24T10:18:03.000Z thumbnail image
  6. Check
    228 days ago
    Change Detected
    Summary
    New recruitment sites have been added across various countries including Bulgaria, China, Colombia, France, Italy, Japan, Poland, Slovakia, Spain, Turkey, and the UK, while one site in Israel has been removed.
    Difference
    6%
    Check dated 2024-11-03T20:58:36.000Z thumbnail image

Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.